HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA’s McClellan Touts Scientific Analysis As Part Of Ephedra Ban

This article was originally published in The Tan Sheet

Executive Summary

FDA Commissioner Mark McClellan, MD/PhD, said the "framework" for the outright ban of ephedra will be based on substantive scientific evidence as the agency prepares to publish the reg

You may also be interested in...

NTP Board Shows Support For More Dietary Supplement Evaluations

Increasing the number of dietary supplements to be evaluated by the National Toxicology Program would be warranted, according to the organization's Board of Scientific Counselors

CFSAN Examines AER Reporting Following Bitter Orange Miscalculation

FDA's Center for Food Safety & Applied Nutrition is in the process of making corrections to its adverse event reporting procedures for bitter orange following a miscalculation of the number of AERs tied to the ingredient

A Bitter Pill? Researchers Challenge Citrus Aurantium Safety, Efficacy

The inclusion of Citrus aurantium in weight-loss products is not supported by substantial clinical evidence, researchers conclude in the September issue of Experimental Biology & Medicine

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts